243 related articles for article (PubMed ID: 30684916)
1. IL-17 and colorectal cancer: From carcinogenesis to treatment.
Razi S; Baradaran Noveiry B; Keshavarz-Fathi M; Rezaei N
Cytokine; 2019 Apr; 116():7-12. PubMed ID: 30684916
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer.
Velikova TV; Miteva L; Stanilov N; Spassova Z; Stanilova SA
World J Gastroenterol; 2020 Apr; 26(16):1912-1925. PubMed ID: 32390702
[TBL] [Abstract][Full Text] [Related]
3. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.
Amicarella F; Muraro MG; Hirt C; Cremonesi E; Padovan E; Mele V; Governa V; Han J; Huber X; Droeser RA; Zuber M; Adamina M; Bolli M; Rosso R; Lugli A; Zlobec I; Terracciano L; Tornillo L; Zajac P; Eppenberger-Castori S; Trapani F; Oertli D; Iezzi G
Gut; 2017 Apr; 66(4):692-704. PubMed ID: 26719303
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer progression is associated with accumulation of Th17 lymphocytes in tumor tissues and increased serum levels of interleukin-6.
Li X; Wang Y; Han C; Li P; Zhang H
Tohoku J Exp Med; 2014 Jul; 233(3):175-82. PubMed ID: 24990228
[TBL] [Abstract][Full Text] [Related]
5. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.
Zhang Y; Davis C; Shah S; Hughes D; Ryan JC; Altomare D; Peña MM
Mol Carcinog; 2017 Jan; 56(1):272-287. PubMed ID: 27120577
[TBL] [Abstract][Full Text] [Related]
6. Dynamic stromal cellular reaction throughout human colorectal adenoma-carcinoma sequence: A role of TH17/IL-17A.
Cui G; Li Z; Florholmen J; Goll R
Biomed Pharmacother; 2021 Aug; 140():111761. PubMed ID: 34044278
[TBL] [Abstract][Full Text] [Related]
7. [Role of Th17 lymphocytes in pathogenesis of colorectal cancer].
Karczewski J; Mazur M; Rychlewska-Hańczewska A; Adamski Z
Postepy Hig Med Dosw (Online); 2014 Jan; 68():42-7. PubMed ID: 24491894
[TBL] [Abstract][Full Text] [Related]
8. The role of interleukin-17A in colorectal tumorigenesis.
Shi Y; Lin H; Cui J; Qi H; Florholmen J; Liu Z; Cui G
Cancer Biother Radiopharm; 2013; 28(6):429-32. PubMed ID: 23701420
[TBL] [Abstract][Full Text] [Related]
9. Th17 cytokine profiling of colorectal cancer patients with or without enterovirus 71 antigen expression.
Li Y; Qiu Q; Fan Z; He P; Chen H; Jiao X
Cytokine; 2018 Jul; 107():35-42. PubMed ID: 29175261
[TBL] [Abstract][Full Text] [Related]
10. Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients.
Zhao L; Zhang X; Zhou Y; Fu K; Lau HC; Chun TW; Cheung AH; Coker OO; Wei H; Wu WK; Wong SH; Sung JJ; To KF; Yu J
Oncogene; 2022 Sep; 41(36):4200-4210. PubMed ID: 35882981
[TBL] [Abstract][Full Text] [Related]
11. Roles for Interleukin 17 and Adaptive Immunity in Pathogenesis of Colorectal Cancer.
Hurtado CG; Wan F; Housseau F; Sears CL
Gastroenterology; 2018 Dec; 155(6):1706-1715. PubMed ID: 30218667
[TBL] [Abstract][Full Text] [Related]
12. CD19
Mao H; Pan F; Wu Z; Wang Z; Zhou Y; Zhang P; Gou M; Dai G
DNA Cell Biol; 2017 Oct; 36(10):870-877. PubMed ID: 28829194
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral regulatory T cells are associated with suppression of colorectal carcinoma metastasis after resection through overcoming IL-17 producing T cells.
Wang Q; Feng M; Yu T; Liu X; Zhang P
Cell Immunol; 2014 Feb; 287(2):100-5. PubMed ID: 24487033
[TBL] [Abstract][Full Text] [Related]
14. [Correlations between tumor infiltrating Th17 cells and clinicopathological parameters in patients with colorectal cancer].
Wang J; Zhang L; Tie Y; Lv Y; Song J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Mar; 30(3):302-5. PubMed ID: 24606752
[TBL] [Abstract][Full Text] [Related]
15. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17: a promoter in colorectal cancer progression.
Wu D; Wu P; Huang Q; Liu Y; Ye J; Huang J
Clin Dev Immunol; 2013; 2013():436307. PubMed ID: 24382972
[TBL] [Abstract][Full Text] [Related]
17. Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer.
Song Y; Yang JM
Biochem Biophys Res Commun; 2017 Nov; 493(1):1-8. PubMed ID: 28859982
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.
Chung S; Dwabe S; Elshimali Y; Sukhija H; Aroh C; Vadgama JV
PLoS One; 2015; 10(8):e0134948. PubMed ID: 26258407
[TBL] [Abstract][Full Text] [Related]
19. IL-17, IL-21, and IL-22 Cytokines of T Helper 17 Cells in Cancer.
Nalbant A
J Interferon Cytokine Res; 2019 Jan; 39(1):56-60. PubMed ID: 30562123
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells.
Thomson A; Bento DFC; Scurr MJ; Smart K; Somerville MS; Keita ÅV; Gallimore A; Godkin A
Br J Cancer; 2021 Apr; 124(9):1552-1555. PubMed ID: 33674735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
